首页> 外文期刊>European heart journal. Acute cardiovascular care >Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study
【24h】

Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study

机译:在BWH-TIMI ED胸痛研究中评估当前和下一代心脏肌钙蛋白I的诊断性能

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Rapid diagnosis of acute coronary syndrome is a clinical and operational priority in busy emergency departments (ED). We examined the performance of an investigational troponin I (Tnl) assay with 10-100-times greater sensitivity than current commercial assays. Methods: Among patients with non-traumatic chest pain enrolled in the BWH-TIMI ED Chest Pain Study, we measured Tnl (n=381) at baseline, 4-6 h, and 12-24 h with an investigational assay (S-Tnl; Singulex, detection-limit 0.0002 ug/l, 99th percentile 0.009 ug/l) and a contemporary sensitive assay (Tnl-Ultra; Siemens, detection-limit 0.006 ug/l, 99th percentile 0.04 ug/l). Final diagnosis was adjudicated using all diagnostic data and local hospital-based cardiac Tnl (Siemens), blinded to investigational cardiac Tn. Results: The adjudicated diagnosis was myocardial infarction (Ml) in 96 patients, unstable angina in 41, and acute non-coronary cardiovascular conditions in 50 patients. Baseline S-Tnl was highly sensitive for Ml (97%, 95% Cl 91-99%) with specificity 81 % (95% Cl 76-86%) and positive predictive value 63% (95% Cl 55-71%). The negative predictive value with S-Tnl was 99% (95% Cl 96-100%). S-Tnl had better diagnostic accuracy than the local assay (area under the curve 0.976 vs. 0.916, p=0.003). Among 20 patients with negative baseline Tnl and diagnosis of Ml, 19 had elevated baseline S-Tnl. Compared to Tnl-Ultra, S-Tnl trended toward higher sensitivity (97 vs. 94%, p=NS) but did not differ significantly in negative predictive value (99 vs. 98%) or area under the curve (p=0.29). Conclusion: Current and investigational Tn assays substantially increased clinical sensitivity and improved diagnostic accuracy for Ml, despite a decline in specificity. A contemporary sensitive assay delivered similar overall accuracy to the investigational test, suggesting that we have reached a point of maximum diagnostic return with increasing analytical sensitivity.
机译:背景:在繁忙的急诊科(ED)中,快速诊断急性冠状动脉综合征是临床和操作上的优先事项。我们检查了肌钙蛋白I(Tnl)研究性测定的性能,其灵敏度比目前的商业测定高10到100倍。方法:在参加BWH-TIMI ED胸痛研究的非创伤性胸痛患者中,我们通过研究性测定(S-Tnl)在基线,4-6小时和12-24小时测量了Tnl(n = 381)。 ; Singulex的检出限为0.0002 ug / l,第99个百分位数为0.009 ug / l)和当代灵敏度测定法(Tnl-Ultra; Siemens的检出限为0.006 ug / l,第99个百分位数为0.04 ug / l)。使用所有诊断数据和当地基于医院的心脏Tnl(Siemens)对最终的诊断作出判断,对研究性心脏Tn不知情。结果:裁定的诊断为96例心肌梗死(M1),41例不稳定型心绞痛和50例急性非冠心病。基线S-Tnl对M1(97%,95%Cl 91-99%)高度敏感,特异性为81%(95%Cl 76-86%),阳性预测值为63%(95%Cl 55-71%)。 S-Tnl的阴性预测值为99%(95%Cl 96-100%)。 S-Tnl的诊断准确性高于局部检测(曲线下面积0.976对0.916,p = 0.003)。在基线Tnl阴性且诊断为M1的20名患者中,有19名基线S-Tnl升高。与Tnl-Ultra相比,S-Tnl倾向于更高的灵敏度(97%vs. 94%,p = NS),但阴性预测值(99%vs. 98%)或曲线下面积(p = 0.29)没有显着差异。 。结论:尽管特异性下降,当前的和研究性的Tn试验仍大大提高了M1的临床敏感性和诊断准确性。当代的灵敏测定提供了与研究测试相似的总体准确性,这表明随着分析灵敏度的提高,我们已经达到了最大的诊断回报率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号